Clinical

Latest News

January 1st 2000

Celltrion Presents More Data Showing Comparable Efficacy, Safety of Subcutaneous CT-P13 to IV Form

Korean drug maker Celltrion Healthcare recently presented new findings from a 2-part study at the Annual European Congress of Rheumatology 2019 meeting about subcutaneous biosimilar CT-P13 (Inflectra, Remsima).

Latest Videos

Screening for Eye Problems in Patients With Diabetes

Diabetic Macular Edema and Other Diabetes-Related Eye Diseases: The Cost Burden

Daniel J. Klein Explains How PAN Reduces Barriers to Care

Dr Joseph Kvedar: Medical Leadership Needs to Take Lead on New Technologies

Dr Georges Benjamin: Healthcare Diversity Has to Start at the Very Top

This Week in Managed Care: February 27, 2016

Jack Whelan: Getting Patients Involved in Their Care

Daniel J. Klein Highlights Barriers to Accessing Innovative Oncology Care

Dr Dana Goldman Outlines How to Meet the Needs of Patients With Mental Illness

This Week in Managed Care: February 20, 2016

More News

Trending on AJMC

CMS Final Rule Ends Federal Medicaid, CHIP Funding for Youth Gender-Affirming Care

Trump Childhood Vaccine Order: What It Means for Parents and Payers

CAR T, Bispecifics Reshape Relapsed Lymphoma Care: Madhav Seshadri, MD

OCTOPUS Trial Aims to Speed Access to Rare Sarcoma Drugs

Employers With Claims Data Access Take More Cost Action, Survey Finds